Evaluation status available after sign-in
About the journal
Molecular & Cellular Oncology is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,615 EUR. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Taylor & Francis Group
- ISSN
- 2372-3548 · 2372-3556
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,615 EUR
- Articles in DOAJ
- 591
- Declared review time
- 6 weeks
- Declared peer-review model
- other
- Official website
- https://www.tandfonline.com/journals/kmco20
Index listings
- DOAJ · 2022-09-14
- PUBMED · 2015-10-01
- Indexing
- DOAJ · PUBMED
- APC
- 1,615 EUR
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
591
Most recent article
last month
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
1039
Last recorded publication year
2025
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
44
i10-index
351
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2023-07-18
- Added to DOAJ
- 2022-09-14
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 77%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Mol Cell OncolMolecular and cellular oncologyMCO
- Source type
- journal
- NLM unique ID (PubMed)
- 101642411
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Cancer-related Molecular Pathways
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- Cell death mechanisms and regulation
- DNA Repair Mechanisms
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Autophagy in Disease and Therapy
Show all subjects (75)
- Cancer, Hypoxia, and Metabolism
- Cancer-related Molecular Pathways
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- RNA modifications and cancer
- RNA modifications and cancer
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- PI3K/AKT/mTOR signaling in cancer
- Ubiquitin and proteasome pathways
- Chromatin Remodeling and Cancer
- Genomics and Chromatin Dynamics
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
- Genomics and Chromatin Dynamics
- Genomics and Chromatin Dynamics
- Protein Kinase Regulation and GTPase Signaling
- Metabolism, Diabetes, and Cancer
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer Genomics and Diagnostics
- Mitochondrial Function and Pathology
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Mitochondrial Function and Pathology
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Cancer-related gene regulation
- Cancer-related gene regulation
- Endoplasmic Reticulum Stress and Disease
- Endoplasmic Reticulum Stress and Disease
- Epigenetics and DNA Methylation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Telomeres, Telomerase, and Senescence
- RNA Research and Splicing
- RNA Research and Splicing
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Mitochondrial Function and Pathology
- Acute Myeloid Leukemia Research
- Metabolism, Diabetes, and Cancer
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Metabolism, Diabetes, and Cancer
- Melanoma and MAPK Pathways
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Histone Deacetylase Inhibitors Research
- Cancer-related molecular mechanisms research
- Histone Deacetylase Inhibitors Research
- TGF-β signaling in diseases
- Glioma Diagnosis and Treatment
- Cancer-related molecular mechanisms research
- Genetics, Aging, and Longevity in Model Organisms
- Lung Cancer Treatments and Mutations
Keywords (DOAJ)
- oncology
- molecular oncology
- cellular oncology
- oncogenesis
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ